Zivo Bioscience terminates CEO Andrew Dahl for cause; Dahl resigns from board

Zivo Bioscience, Inc.

CEO Andrew A. Dahl terminated for cause on Jan 4, 2022 after declining to resign; no separation agreement reached.
On Feb 18, 2022, Dahl resigned from the board of directors; board size reduced to four members.
Principal executive office moved to 21 E. Long Lake Road, Suite 100, Bloomfield Hills, MI effective Feb 21, 2022.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Andrew A. Dahl

member of the board of directors

ZIVO · Zivo Bioscience, Inc.

Effective: 2022-02-18
Filed: February 25, 2022, 6:59 PM ET

on February 18, 2022, Mr. Dahl resigned from his position as a member of the Company’s board of directors.

Departed

Andrew A. Dahl

President and Chief Executive Officer

ZIVO · Zivo Bioscience, Inc.

Effective: 2022-01-04
Filed: February 25, 2022, 6:59 PM ET

the Company terminated the employment of Andrew A. Dahl, the President and Chief Executive Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew A. Dahl resigned as member of the board of directors at Zivo Bioscience, Inc..

Action: resigned
Role: member of the board of directors

Exact text from the filing

on February 18, 2022, Mr. Dahl resigned from his position as a member of the Company’s board of directors.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew A. Dahl was terminated as President and Chief Executive Officer at Zivo Bioscience, Inc..

Action: terminated
Role: President and Chief Executive Officer

Exact text from the filing

the Company terminated the employment of Andrew A. Dahl, the President and Chief Executive Officer of the Company.

View on SEC.gov

Zivo Bioscience, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-22-002090

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.